Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Radiol. Nov 28, 2025; 17(11): 114193
Published online Nov 28, 2025. doi: 10.4329/wjr.v17.i11.114193
Published online Nov 28, 2025. doi: 10.4329/wjr.v17.i11.114193
Value of radiomics models in precision diagnosis of dual-phenotype hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Xu Qi, Department of Radiology, Peking Union Medical College Hospital, Beijing 100730, China
Fei-Yu Zhao, Department of Radiation Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China
Author contributions: Qi X and Zhao FY contributed to manuscript writing, provided ideas for the draft, and revised the article.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Fei-Yu Zhao, PhD, Department of Radiation Oncology, The Fifth Medical Center of Chinese PLA General Hospital, No. 8 East Main Street, Fengtai District, Beijing 100071, China. 1029279130@qq.com
Received: September 17, 2025
Revised: October 3, 2025
Accepted: November 4, 2025
Published online: November 28, 2025
Processing time: 75 Days and 0.3 Hours
Revised: October 3, 2025
Accepted: November 4, 2025
Published online: November 28, 2025
Processing time: 75 Days and 0.3 Hours
Core Tip
Core Tip: A recent study published by Zhang et al focuses on exploring the practical value of radiomics in ahcieving the differential diagnosis between dual-phenotype hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Its constructed com
